Logo
Login
$FULC
$3.64 -$0.04 (1.09%) Close

Company Executives

$FULC Management Team

Mr. Alex Sapir

President

Chief Executive Officer

Director

Age 58
Compensation $1.003M USD
Sex Male

Ms. Kate Haviland

Independent Chairman of the Board

Age 49
Compensation $249.1K USD
Sex Female

Mr. Alan Musso

Chief Financial Officer

Age 63
Compensation $1.252M USD
Sex Male

Mr. Curtis Oltmans

Chief Legal Officer

Age 61
Compensation $1.425M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 30, 2026
Directors
10
serving now
Independent
0 of 2
stated in the proxy; 8 not stated
Average tenure
5.6 years
from year joined
CEO also chairs the board
No
Kate Haviland
Director Age On board Independent Committees Other public boards 2025 pay Source
Sonja Banks
57 2021
5 years
 Not stated
Nominating and Corporate Governance
None stated $263,406
Alan Ezekowitz
72 2016
10 years
 Not stated
Compensation and Human Capital Management Science and Technology
Organon & Co. $273,047
Colin Hill
53 2024
2 years
 Not stated
Science and Technology
None stated $264,406
James Geraghty
71 2016
10 years
 Not stated
Audit Nominating and Corporate Governance · Chair
Voyager Therapeutics, Inc. $274,906
Rachel King
66 2024
2 years
 Not stated
Compensation and Human Capital Management · Chair
Novavax, Inc. $265,765
Alex C. Sapir
CEO
 59 2023
3 years
 Not independent None stated None stated Paid as CEO
Katina Dorton
68 2020
6 years
 Not stated
Audit · Chair Compensation and Human Capital Management
Tscan Therapeutics, Inc. $279,406
Robert J. Gould
71 2016
10 years
 Not independent
Science and Technology · Chair
None stated $269,406
Kate Haviland
Board chair
 50 2018
8 years
 Not stated
Audit Nominating and Corporate Governance
Bicara Therapeutics Inc. $300,906
Josh Lehrer
52 2026
0 years
 Not stated None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans